Patient Preference for Calcipotriene 0.005%/Betamethasone Dipropionate 0.064% Foam or Topical Suspension vs. Latest Topical Treatment in the PSO-INSIGHTFUL Study

Main Article Content

Jennifer Soung
Lisa Tiu
Karen Veverka
Chih-Ho Hong

Keywords

psoriasis, calcipotriene, betamethasone,

Abstract

Abstract Not Available